Clinical Phase II, III Intermediates
GMP Custom synthesis, Full Document
R&D Center: 8000 sq, More than 100 hoods
Pilot Plant: 20000sq, 40 reactors from 5-200L
Manufacturing Site: 800000sq, 40 reactors from 100-5000L
Web: www.eosmedchem.com
Email: info@eosmedchem.com; eosmedchem@gmail.com
This is my R&D youtube: https://youtu.be/r5cJdXKNXHk
| FK-614, 193012-35-0, FK-614 Intermediate 84228-43-3, stock 646g, white powder, assay by HPLC 99.1%, HNMR, LCMS we supply. |
| FK-614, 193012-35-0, FK-614 Intermediate 193013-89-7, stock 577.9g, white powder, assay by HPLC 98.5%, HNMR, LCMS we supply. |
| FK-614, 193012-35-0, FK-614 Intermediate 94-99-5, stock 370.3g, white powder, assay by HPLC 99.5%, HNMR, LCMS we supply. |
| FK-614, 193012-35-0, FK-614 Intermediate 219763-39-0, stock 841.5g, white powder, assay by HPLC 99.7%, HNMR, LCMS we supply. |
| FK-614, 193012-35-0, FK-614 Intermediate 193009-93-7, stock 970.2g, white powder, assay by HPLC 99.4%, HNMR, LCMS we supply. |
| FK-614, 193012-35-0, FK-614 Intermediate 193010-16-1, stock 427.7g, white powder, assay by HPLC 98.4%, HNMR, LCMS we supply. |
| FK-614, 193012-35-0, FK-614 Intermediate 52960-14-2, stock 998g, white powder, assay by HPLC 98.3%, HNMR, LCMS we supply. |
| FK-614, 193012-35-0, FK-614 Intermediate 193012-35-0, stock 844.6g, white powder, assay by HPLC 98.1%, HNMR, LCMS we supply. |
